Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Association between northern Manhattan study global vascular risk score and successful aging.

Warsch JR, Rundek T, Paik MC, Elkind MS, Sacco RL, Wright CB.

J Am Geriatr Soc. 2013 Apr;61(4):519-24. doi: 10.1111/jgs.12166. Epub 2013 Mar 25.

2.

Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).

Sacco RL, Khatri M, Rundek T, Xu Q, Gardener H, Boden-Albala B, Di Tullio MR, Homma S, Elkind MS, Paik MC.

J Am Coll Cardiol. 2009 Dec 8;54(24):2303-11. doi: 10.1016/j.jacc.2009.07.047.

3.
4.

Modeling metabolic syndrome and its association with cognition: the Northern Manhattan study.

Levin BE, Llabre MM, Dong C, Elkind MS, Stern Y, Rundek T, Sacco RL, Wright CB.

J Int Neuropsychol Soc. 2014 Nov;20(10):951-60. doi: 10.1017/S1355617714000861. Epub 2014 Nov 10.

5.

Prevalence and determinants of subclinical brain infarction: the Northern Manhattan Study.

Prabhakaran S, Wright CB, Yoshita M, Delapaz R, Brown T, DeCarli C, Sacco RL.

Neurology. 2008 Feb 5;70(6):425-30. Epub 2007 Sep 26.

6.

Infectious Burden and Cognitive Decline in the Northern Manhattan Study.

Wright CB, Gardener H, Dong C, Yoshita M, DeCarli C, Sacco RL, Stern Y, Elkind MS.

J Am Geriatr Soc. 2015 Aug;63(8):1540-5. doi: 10.1111/jgs.13557.

7.

Daytime sleepiness and risk of stroke and vascular disease: findings from the Northern Manhattan Study (NOMAS).

Boden-Albala B, Roberts ET, Bazil C, Moon Y, Elkind MS, Rundek T, Paik MC, Sacco RL.

Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):500-7. doi: 10.1161/CIRCOUTCOMES.111.963801. Epub 2012 Jul 10.

8.

Vascular risk factors and cognitive impairment in chronic kidney disease: the Chronic Renal Insufficiency Cohort (CRIC) study.

Kurella Tamura M, Xie D, Yaffe K, Cohen DL, Teal V, Kasner SE, Messé SR, Sehgal AR, Kusek J, DeSalvo KB, Cornish-Zirker D, Cohan J, Seliger SL, Chertow GM, Go AS.

Clin J Am Soc Nephrol. 2011 Feb;6(2):248-56. doi: 10.2215/CJN.02660310. Epub 2010 Oct 7.

9.

Stroke risk factors and loss of high cognitive function.

Elkins JS, O'Meara ES, Longstreth WT Jr, Carlson MC, Manolio TA, Johnston SC.

Neurology. 2004 Sep 14;63(5):793-9.

PMID:
15365125
10.

Ideal Cardiovascular Health and Cognitive Aging in the Northern Manhattan Study.

Gardener H, Wright CB, Dong C, Cheung K, DeRosa J, Nannery M, Stern Y, Elkind MS, Sacco RL.

J Am Heart Assoc. 2016 Mar 16;5(3):e002731. doi: 10.1161/JAHA.115.002731.

11.

Insulin resistance and risk of ischemic stroke among nondiabetic individuals from the northern Manhattan study.

Rundek T, Gardener H, Xu Q, Goldberg RB, Wright CB, Boden-Albala B, Disla N, Paik MC, Elkind MS, Sacco RL.

Arch Neurol. 2010 Oct;67(10):1195-200. doi: 10.1001/archneurol.2010.235.

12.

Diabetes, fasting glucose levels, and risk of ischemic stroke and vascular events: findings from the Northern Manhattan Study (NOMAS).

Boden-Albala B, Cammack S, Chong J, Wang C, Wright C, Rundek T, Elkind MS, Paik MC, Sacco RL.

Diabetes Care. 2008 Jun;31(6):1132-7. doi: 10.2337/dc07-0797. Epub 2008 Mar 13.

PMID:
18339972
13.

Black-white disparities in functional decline in older persons: the role of cognitive function.

Moody-Ayers SY, Mehta KM, Lindquist K, Sands L, Covinsky KE.

J Gerontol A Biol Sci Med Sci. 2005 Jul;60(7):933-9.

PMID:
16079221
14.

Population attributable risks of hypertension and diabetes for cardiovascular disease and stroke in the northern Manhattan study.

Willey JZ, Moon YP, Kahn E, Rodriguez CJ, Rundek T, Cheung K, Sacco RL, Elkind MS.

J Am Heart Assoc. 2014 Sep 16;3(5):e001106. doi: 10.1161/JAHA.114.001106.

15.

Body mass index, lifestyles, physical performance and cognitive decline: the "Treviso Longeva (TRELONG)" study.

Gallucci M, Mazzuco S, Ongaro F, Di Giorgi E, Mecocci P, Cesari M, Albani D, Forloni GL, Durante E, Gajo GB, Zanardo A, Siculi M, Caberlotto L, Regini C.

J Nutr Health Aging. 2013 Apr;17(4):378-84. doi: 10.1007/s12603-012-0397-1.

PMID:
23538662
16.

Serum adiponectin in relation to race-ethnicity and vascular risk factors in the Northern Manhattan Study.

Gardener H, Crisby M, Sjoberg C, Hudson B, Goldberg R, Mendez AJ, Wright CB, Rundek T, Elkind MS, Sacco RL.

Metab Syndr Relat Disord. 2013 Feb;11(1):46-55. doi: 10.1089/met.2012.0065. Epub 2012 Nov 5.

17.

Clinical and radiological determinants of prestroke cognitive decline in a stroke cohort.

Pohjasvaara T, Mäntylä R, Aronen HJ, Leskelä M, Salonen O, Kaste M, Erkinjuntti T.

J Neurol Neurosurg Psychiatry. 1999 Dec;67(6):742-8.

18.

Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up.

Annweiler C, Rolland Y, Schott AM, Blain H, Vellas B, Herrmann FR, Beauchet O.

J Gerontol A Biol Sci Med Sci. 2012 Nov;67(11):1205-11. doi: 10.1093/gerona/gls107. Epub 2012 Apr 13.

PMID:
22503994
19.

Predictors of combined cognitive and physical decline.

Atkinson HH, Cesari M, Kritchevsky SB, Penninx BW, Fried LP, Guralnik JM, Williamson JD.

J Am Geriatr Soc. 2005 Jul;53(7):1197-202.

PMID:
16108938
20.

Risk factors for non-insulin-dependent diabetes mellitus requiring treatment in the elderly.

Gurwitz JH, Field TS, Glynn RJ, Manson JE, Avorn J, Taylor JO, Hennekens CH.

J Am Geriatr Soc. 1994 Dec;42(12):1235-40.

PMID:
7983284

Supplemental Content

Support Center